TY - JOUR
T1 - A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice
AU - Tichelaar, Jay W.
AU - Yan, Ying
AU - Tan, Qing
AU - Wang, Yian
AU - Estensen, Richard D.
AU - Young, Matthew R.
AU - Colburn, Nancy H.
AU - Yin, Hulian
AU - Goodin, Colleen
AU - Anderson, Marshall W.
AU - You, Ming
PY - 2010/9
Y1 - 2010/9
N2 - Lung cancer is the leading cause of cancer mortality in the United States and worldwide. The identification of key regulatory and molecular mechanisms involved in lung tumorigenesis is therefore critical to increase our understanding of this disease and could ultimately lead to targeted therapies to improve prevention and treatment. Induction of members of the activator protein-1 (AP-1) transcription factor family has been described in human non-small cell lung carcinoma. Activation of AP-1 can either stimulate or repress transcription of multiple gene targets, ultimately leading to increased cell proliferation and inhibition of apoptosis. In the present study, we show induction of AP-1 in carcinogen-induced mouse lung tumors compared with surrounding normal lung tissue. We then used a transgenic mouse model directing conditional expression of the dominant-negative c-jun mutant TAM67 in lung epithelial cells to determine the effect of AP-1 inhibition on mouse lung tumorigenesis. Consistent with low AP-1 activity in normal lung tissue, TAM67 expression had no observed effects in adult mouse lung. TAM67 decreased tumor number and overall lung tumor burden in chemically induced mouse lung tumor models. The most significant inhibitory effect was observed on carcinoma burden compared with lower-grade lesions. Our results support the concept that AP-1 is a key regulator of mouse lung tumorigenesis, and identify AP-1-dependent transcription as a potential target to prevent lung tumor progression.
AB - Lung cancer is the leading cause of cancer mortality in the United States and worldwide. The identification of key regulatory and molecular mechanisms involved in lung tumorigenesis is therefore critical to increase our understanding of this disease and could ultimately lead to targeted therapies to improve prevention and treatment. Induction of members of the activator protein-1 (AP-1) transcription factor family has been described in human non-small cell lung carcinoma. Activation of AP-1 can either stimulate or repress transcription of multiple gene targets, ultimately leading to increased cell proliferation and inhibition of apoptosis. In the present study, we show induction of AP-1 in carcinogen-induced mouse lung tumors compared with surrounding normal lung tissue. We then used a transgenic mouse model directing conditional expression of the dominant-negative c-jun mutant TAM67 in lung epithelial cells to determine the effect of AP-1 inhibition on mouse lung tumorigenesis. Consistent with low AP-1 activity in normal lung tissue, TAM67 expression had no observed effects in adult mouse lung. TAM67 decreased tumor number and overall lung tumor burden in chemically induced mouse lung tumor models. The most significant inhibitory effect was observed on carcinoma burden compared with lower-grade lesions. Our results support the concept that AP-1 is a key regulator of mouse lung tumorigenesis, and identify AP-1-dependent transcription as a potential target to prevent lung tumor progression.
UR - http://www.scopus.com/inward/record.url?scp=77956408222&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956408222&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-10-0023
DO - 10.1158/1940-6207.CAPR-10-0023
M3 - Article
C2 - 20716630
AN - SCOPUS:77956408222
SN - 1940-6207
VL - 3
SP - 1148
EP - 1156
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 9
ER -